Effect of Sinovac on Survival in Intensive Care Unit

Sisli Hamidiye Etfal Training and Research Hospital

Status: Completed

Conditions: Survival; Intensive Care Unit

Study type: Observational

Funder types: Other

Identifiers

NCT04956562

1903

Details and patient eligibility

About

Effect of Inactivated COVID-19 Vaccine (Sinovac) on survival in intensive care unit, Single Center Experience

Full description

Turkey has started vaccinate healthcare professionals at 13 January 2021 by Sinovac vaccine and declared a step by step inclusion schedule The primary aim of the study is to compare clinical, laboratory and survival data of COVID-19 patients who were vaccinated at least 14 days before enrollment to the study with COVID-19 patients not vaccinated although they would have. The secondary aim is to compare age of enrolled patients to ICU due to SARS-CoV-2 infection with patients admitted to ICU before start of vaccination program.

Enrollment: 96 patients

Sex: All

Ages: 65+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with covid 19 over the age of 65 who were admitted to the intensive care unit between 1 April 2021 and 15 May 2021

Exclusion criteria

• admissions to ICU due to reasons other than COVID-19, age younger than 65, continued admission at the end of enrolment date,

Trial design

96 participants in 2 patient groups

Vaccinated with sinovac

Description:

Vaccinated COVID-19 patients over 65 years consisted the study group

Unvaccinated

Description:

Unvaccinated patients over 65 years composed the control group